Skip to content
FrontierPicks

Momentum leaders · current

US momentum leaders — October 2026

As of 8 October 2026

KOD is up 179.0% over one month, IOVA is up 214.7% over three months, and GRAL is up 84.2% over three months. Healthcare stocks lead October's list, with a smaller group of technology, financial and consumer names behind them. As of 9 October, the market had moved from a risk-off regime to a neutral one, and the VIX was calm at 15.41.

# Name 3-mo price move
1
KOD
+128.2%

Kodiak Sciences' DAYBREAK win in wet AMD looks largely priced in, with the shares near the consensus target, deeply overbought and a launch still…

2
GRAL
+84.2%

GRAIL's shares already price in FDA approval of its Galleri cancer blood test and slipped to $132.61 on 8 October 2026 as new trial data arrived.…

3
VRA
+26.1%

Vera Bradley's shares have run past published analyst targets on one tariff-refund-aided quarter, so the case now depends on the December…

4
IOVA
+214.7%

Iovance Biotherapeutics' raised FY2026 revenue guidance of $410–420 million, set two days before Q3 closed, still carries the case after a 229.5%…

5
XP
+78.5%

XP Inc. shares have priced in a market-friendly Brazilian election, rising 84.5% in three months to a record $30.21 close on 8 October 2026. The…

6
LFCR
+35.4%
7
P
+89.8%

Everpure's $7.0–7.3 billion fiscal-2028 revenue outlook has lifted the shares to a record $143.88 close, at or above most average analyst targets…

8
PTC
+55.3%
9
PS
+56.0%
10
RXO
+10.2%
11
MRNA
+188.6%

Moderna's shares price in a strong Phase 3 melanoma result for its Merck-partnered cancer vaccine intismeran autogene. The 24 October 2026 ESMO…

12
PRTH
+9.7%
13
FOSL
+69.5%

Fossil Group's shares hit a 52-week high of $6.80 on 1 October 2026 on the margin turnaround reported in August. The estimated mid-November Q3…

14
LUXE
+32.1%

LuxExperience's turnaround has lifted the shares near their $10.51 annual high and above most analyst targets; the fiscal first-quarter report,…

15
SSTI
−4.5%
16
VICR
−3.6%

Vicor Corporation's patent royalties on its Vertical Power Delivery technology drove two September guidance raises to more than 30% sequential…

17
SG
+14.5%

Sweetgreen's shares have extended their recovery from the summer cyclospora outbreak to $9.57, above every consensus target; the third-quarter…

18
ACVA
+56.5%
19
PENG
−8.7%

Penguin Solutions' memory-led AI-infrastructure case strengthened after the 6 October beat and a fiscal 2027 sales outlook of about 40% growth.…

20
PCRX
+42.8%
21
LIND
+34.0%
22
SDGR
+60.0%

Schrödinger's shares still trade well above the $20.80 consensus target after falling 11.3% to $28.90 on 6 October 2026, because software revenue…

23
RBRK
+43.3%

Rubrik's 33% subscription ARR growth supports the business, but the shares already trade at the $120 consensus target. The early-December report…

24
RSKD
+56.7%
25
LTRX
+22.0%

Lantronix is becoming a supplier of computing modules for military drones, backed by a Pentagon Blue UAS listing on 1 October 2026; the fiscal…

26
NTSK
+59.2%

Netskope's 29% revenue growth and raised fiscal 2027 outlook keep its shares just above the $19.08 average analyst target. The fiscal Q3 report…

27
ANGI
+0.6%
28
MYGN
−28.0%

Myriad Genetics shares trade on one broker's $8 recovery call while revenue per test is still falling; the third-quarter report, expected around 2…

29
XERS
+22.2%
30
INTR
+24.4%

Inter & Co.'s record profits now come with an election-driven 32% four-day jump in its shares; Brazil's 25 October 2026 presidential runoff…

31
SILC
+28.7%

Silicom's networking-card revenue rose 59% in Q2 2026 and a first AI inference order adds a second growth line, with the shares now back below…

32
MXL
+2.6%

MaxLinear's shares fell 13% to $93.70 on 8 October 2026 after a 45% one-month rally yet still sit above the $88.64 average analyst target; the 22…

33
OPCH
+44.0%
34
S
+42.1%

SentinelOne's shares hold near a 52-week high on its AI-security story while net new recurring revenue grew only 4% and executives sold into the…

35
IMOS
−0.4%

ChipMOS posted record third-quarter 2026 revenue of NT$8,400.8 million, but monthly sales were flat from August to September and its US shares…

36
ECO
+87.3%

Record supertanker freight in October 2026 points to Okeanis Eco Tankers earning far above the rates it booked by August. The 11 November 2026…

37
FPS
−13.0%

Forgent Power Solutions' $3.0 billion backlog and above-consensus fiscal 2027 guidance still run ahead of its shares, which closed at $39.80 on 8…

38
ZS
+55.7%

Zscaler's 6 October investor day reaffirmed fiscal 2027 guidance and set a path to more than $8 billion of recurring revenue by fiscal 2031,…

39
SHOP
+34.3%

Shopify is growing revenue above 30% a year and is the checkout layer for Meta's Muse shopping agent; its third-quarter 2026 report on 3 November…

40
TTAN
−6.1%
41
ILMN
+39.1%

Illumina's clinical sequencing recovery is intact, but the shares slid to $264.57 on 8 October 2026 after reversing from a $309.35 intraday high…

42
ONON
−11.7%

On Holding's 2029 goal of at least CHF 5.6 billion in sales and its first $1 billion buyback have lifted the shares off their 52-week low. The Q3…

43
SYNA
−6.1%
44
SBS
+8.7%

Sabesp's shares now trade on Brazil's 25 October presidential runoff more than on its water business: the first-round rally lifted the ADS to…

45
CRDO
−17.8%

Credo Technology's revenue is still more than doubling and management expects optical products to lift second-half fiscal 2027 growth. The…

46
MANE
+5.9%

Veradermics' oral minoxidil tablet VDPHL01 has one strongly positive hair-loss trial, and its shares closed at $126.63 on 8 October 2026 after…

47
GME
+16.6%

GameStop's CEO Ryan Cohen has bought shares four times on the open market since 10 September, at rising prices, backing a cash-rich balance sheet…

48
CIEN
−7.6%

Ciena Corporation's AI-driven optical order book, with backlog expected above $10 billion, has lifted the shares off their September lows. The…

49
SNPS
+11.7%
50
OKTA
+58.8%

Okta's shares now fully price its role as the identity layer for AI agents, closing at a $220.21 high on 8 October 2026 near the $223 median…

"3-mo price move" is the stock's market price change, not a FrontierPicks return.

How this board is built

Every name in the US equity universe is scored on a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closing prices, through the last completed session and ranked highest-first. No model orders the board — the ranking is arithmetic. The "3-mo price move" column is one of the three inputs to that score, weighted 20% — not the ranking itself, so rows do not descend in it. The board reflects price moves already made, not a forecast. Each covered name links to its dated research dossier: the thesis, the kill line, the setup type and the next catalyst.

Past months

Each month's board is frozen when the month closes and kept unchanged — the record of what led, when.

Questions

What are the hottest US stocks right now?
As of 8 October 2026, the US names with the strongest composite momentum score on FrontierPicks are KOD, GRAL, VRA, IOVA. This is a momentum ranking of price moves already made — research, not advice.
How is this momentum ranking built?
Every name in the US equity universe is scored on a composite momentum score — 1-month price trend 50%, 3-month trend 20% and acceleration 30% — computed arithmetically from daily closing prices, through the last completed session, then ranked highest-first. The arithmetic is the whole ranking — no model orders the board. Each covered name links to its dated research dossier. Methodology is open.
Is a high ranking a recommendation?
No. The board reflects price moves that have already happened, not a forecast or a recommendation. It is educational research, not investment advice.

As of 8 October 2026 · research, not advice.